Positive Action

Partnership objectives

  1. Delivering greater and meaningful involvement of people living with HIV.
  2. Building capacity in grassroots communities.
  3. Preventing HIV.
  4. Tackling stigma and discrimination.
  5. Testing innovations in education, care and treatment.

Partners publish lessons learned about their projects which they make available to the community and the general public. Partners publish lessons learned about their projects which they make available to the community and the general public. Copyright ViiV Healthcare

What are the health needs and challenges?

HIV and AIDS are social issues as well as medical challenges. Knowing that HIV is transmitted by sexual intercourse, sharing needles and from mother to baby is not enough in itself to guarantee the changes in behavior that can protect people from infection. Nor does the growing availability of ARV drugs around the world mean that everyone who needs treatment will come forward, that they can afford blood tests or good nutrition, or that they understand these drugs must be taken at the right time every day of their lives to avoid dangerous drug resistance.

Description of partnership activities and how they address needs and challenges

The program targets its funds towards projects that fulfill one or more of these criteria:

Delivering greater and meaningful involvement of people living with HIV
The Greater Involvement of People living with HIV (GIPA) principle – the adoption of strategies and practices that deliver the greater and meaningful involvement of people living with HIV in AIDS policy, programing and service delivery has adopted it as one of its criteria for selecting projects and partners.

Building capacity in the community
Communities affected by HIV may face many challenges that require significant resources, time and skills to address. Positive Action has supported the formation of local, regional and global organizations of people living with and affected by HIV and their networks. We continue to support programs that help to build the capacity of communities and their organizations.

Tackling stigma and discrimination
People affected by HIV and AIDS have experienced stigma and discrimination since the first appearance of the epidemic. People's fear of disease and death was compounded by transmission of HIV being sexual and by existing attitudes to some of those most vulnerable to infection.

This stigma remains a real barrier to access to essential services, whether prevention, care or treatment. Self-stigma prevents people from coming forward, while active HIV discrimination is commonly found in communities, public services, health care and the legal system. Stigma is addressed by many Positive Action projects and is the specific target of our work with Vida Digna in Mexico, El Salvador, Honduras, Costa Rica, Guatemala, Nicaragua and Panama.

Testing innovations in education, care and treatment
Where antiretroviral treatment has become available, the success of that provision depends on many factors and some of these have to be addressed by and with the affected community: involving people living with HIV and AIDS (GIPA); tackling discrimination; reducing stigma; education about treatment, adherence, side effects (achieving "treatment literacy"); promoting healthy living and positive health, dignity and prevention. We support programmes along the entire continuum of care, with specific attention to improving adherence and linkage to care in our Positive Action Southern Initiative.

Much progress has been made since the first cases of HIV and AIDS were recognized in the 1980s. However, more work is needed. Major barriers to accessing optimal treatment and care throughout the world still remain. These include a need to strengthen education, support services, local healthcare capacity and capabilities, and to reduce stigma and discrimination. In addition, as people are living longer and ageing with HIV, they are facing new medical, psychological and social challenges. We are focused on reaching out effectively to those affected by and those tackling the HIV pandemic to realize UNAIDS’ vision of zero new HIV infections, zero AIDS-related deaths and zero discrimination.

ViiV seeks out and builds new partnerships, connections and collaborations throughout the HIV community to help achieve these goals. Many of the obstacles facing people living with HIV are influenced by regional and cultural traditions. ViiV believes a collaborative approach is essential both to understanding the challenges associated with HIV and identifying the most appropriate solutions for various regions.

Summary of impact and forward looking information

HIV has had a global impact, but some populations have been more impacted than others. Unfortunately, access to prevention information, disease education and medical care are persistent unmet needs for communities affected by HIV throughout the world.

HIV infection rates continue to mount, especially in vulnerable and marginalized key affected populations. For the past 23 years, Positive Action has been working with these populations to overcome stigma and discrimination and to address these unmet needs. We will continue to support community-based organizations around the globe as long as these basic barriers to access and care exist.


Introduction to Positive Action

Partnership information

Company(ies) GlaxoSmithKline , Pfizer

Partner(s) Elizabeth Glaser Pediatric AIDS Foundation, International HIV/AIDS Alliance, Shionogi, The Foundation for AIDS Research (amFAR), ViiV Healthcare

Type of Partner(s) NGOs, Other Business

Therapeutic Focus Infectious Diseases

Disease(s) HIV/AIDS

Program Type(s) Prevention Programs - Awareness & Outreach

Targeted Population(s) Children, Marginalised / Indigenous People, Men, People with low income, Women

Region(s) East Asia & Pacific, Europe & Central Asia, Latin America & Caribbean, Middle East & North Africa, North America, South Asia, Sub-Saharan Africa

Number of Countries 30

Country(ies) Australia, Belgium, Benin, Burkina Faso, Cameroon, Canada, China, Côte d'Ivoire, Germany, Ghana, India, Italy, Jamaica, Kenya, Lebanon, Mali, Morocco, Nepal, Netherlands, Pakistan, Papua New Guinea, Portugal, Russia, South Africa, Spain, Switzerland, Tanzania, Togo, United Kingdom, United States of America

Start Date 1992

More information The ViiV Healthcare Effect

Anticipated completion date Ongoing